Literature DB >> 16511108

Crystallization and preliminary crystallographic analysis of an aminoglycoside kinase from Legionella pneumophila.

Christopher T Lemke1, Jiyoung Hwang, Bing Xiong, Nicholas P Cianciotto, Albert M Berghuis.   

Abstract

9-Aminoglycoside phosphotransferase type Ia [APH(9)-Ia] is a resistance factor in Legionella pneuemophila, the causative agent of legionnaires' disease. It is responsible for providing intrinsic resistance to the antibiotic spectinomycin. APH(9)-Ia phosphorylates one of the hydroxyl moieties of spectinomycin in an ATP-dependent manner, abolishing the antibiotic properties of this drug. Here, the crystallization and preliminary X-ray studies of this enzyme in two crystal forms is reported. One of the these crystal forms provides diffraction data to a resolution of 1.7 A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16511108      PMCID: PMC1952339          DOI: 10.1107/S1744309105016301

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  22 in total

Review 1.  Aminoglycoside antibiotics. Structures, functions, and resistance.

Authors:  G D Wright; A M Berghuis; S Mobashery
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

2.  An approach to multi-copy search in molecular replacement.

Authors:  A Vagin; A Teplyakov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-12

3.  Structural analyses of nucleotide binding to an aminoglycoside phosphotransferase.

Authors:  D L Burk; W C Hon; A K Leung; A M Berghuis
Journal:  Biochemistry       Date:  2001-07-31       Impact factor: 3.162

Review 4.  Molecular mechanisms that confer antibacterial drug resistance.

Authors:  C Walsh
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

5.  The crystal structure of aminoglycoside-3'-phosphotransferase-IIa, an enzyme responsible for antibiotic resistance.

Authors:  Didier Nurizzo; Steven C Shewry; Michael H Perlin; Scott A Brown; Jaydev N Dholakia; Roy L Fuchs; Taru Deva; Edward N Baker; Clyde A Smith
Journal:  J Mol Biol       Date:  2003-03-21       Impact factor: 5.469

Review 6.  Aminoglycoside antibiotic resistance by enzymatic deactivation.

Authors:  Clyde A Smith; Edward N Baker
Journal:  Curr Drug Targets Infect Disord       Date:  2002-06

Review 7.  The use and resistance to antibiotics in the community.

Authors:  Milan Cizman
Journal:  Int J Antimicrob Agents       Date:  2003-04       Impact factor: 5.283

8.  Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry.

Authors:  Desiree H Fong; Albert M Berghuis
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

Review 9.  Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition.

Authors:  E Azucena; S Mobashery
Journal:  Drug Resist Updat       Date:  2001-04       Impact factor: 18.500

10.  Crystal structure of an aminoglycoside 6'-N-acetyltransferase: defining the GCN5-related N-acetyltransferase superfamily fold.

Authors:  L E Wybenga-Groot; K Draker; G D Wright; A M Berghuis
Journal:  Structure       Date:  1999-05       Impact factor: 5.006

View more
  3 in total

1.  Crystallization and preliminary crystallographic analysis of hygromycin B phosphotransferase from Escherichia coli.

Authors:  Daisuke Iino; Yasuaki Takakura; Mika Kuroiwa; Ryouta Kawakami; Yasuyuki Sasaki; Takayuki Hoshino; Kanju Ohsawa; Akira Nakamura; Shunsuke Yajima
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-07-21

2.  Structure of the antibiotic resistance factor spectinomycin phosphotransferase from Legionella pneumophila.

Authors:  Desiree H Fong; Christopher T Lemke; Jiyoung Hwang; Bing Xiong; Albert M Berghuis
Journal:  J Biol Chem       Date:  2010-01-19       Impact factor: 5.157

3.  Crystal structures of two aminoglycoside kinases bound with a eukaryotic protein kinase inhibitor.

Authors:  Desiree H Fong; Bing Xiong; Jiyoung Hwang; Albert M Berghuis
Journal:  PLoS One       Date:  2011-05-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.